Chen X W, Sun J X, Wang Z N, Gao P, Song Y X, Cao J F, Liu B, Xu H M
Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, China.
Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, China
Genet Mol Res. 2014 Feb 13;13(1):850-9. doi: 10.4238/2014.February.13.3.
Several previous studies have investigated whether the -160C/A epithelial cadherin promoter polymorphism confers an increased risk of diffuse gastric cancer (DGC), but conflicting results have been reported. To explore further the association of this polymorphism with DGC susceptibility, we performed an extensive search of relevant studies and conducted a meta-analysis to obtain a more precise estimate. We conducted a systematic literature search using the databases EMBASE, PubMed, and Web of Knowledge for reports published before August 2012 that met certain criteria. Information was carefully and independently extracted from all eligible publications by 2 of the authors. Twelve distinct data sets from 10 case-control studies were analyzed. They included 1115 cases of DGC and 2965 controls. Although none of the genotypes was associated with DGC risk, a slight trend of increased risk was found among A allele carriers [odds ratio (OR) = 1.237, 95% confidence interval (95%CI), 0.940-1.627], CA heterozygotes (OR = 1.229, 95%CI = 0.938-1.610), and AA homozygotes (OR = 1.146, 95%CI = 0.684-1.918). However, when the cases were stratified by ethnicity, a diverging trend occurred in AA homozygotes between the Asian group (OR = 0.710, 95%CI = 0.328-1.536) and its Caucasian counterpart (OR = 1.434, 95%CI = 0.657-3.131). Taken together, the summarized analyses of these case-control studies demonstrated that the -160A of the epithelial cadherin gene exhibited no significant association with susceptibility for DGC; however, the results suggested that it is a potential genetic risk factor in both Asians and Caucasians. Additional large-scale, well-designed studies are necessary to confirm whether AA homozygosity is a protective factor in Asians.
此前已有多项研究探讨上皮钙黏蛋白基因启动子-160C/A多态性是否会增加弥漫性胃癌(DGC)的发病风险,但报道结果相互矛盾。为进一步探究此多态性与DGC易感性之间的关联,我们广泛检索了相关研究并进行荟萃分析,以获得更精确的评估。我们利用EMBASE、PubMed和Web of Knowledge数据库对2012年8月之前发表的符合特定标准的报告进行了系统的文献检索。由两位作者仔细且独立地从所有符合条件的出版物中提取信息。分析了来自10项病例对照研究的12个不同数据集。其中包括1115例DGC病例和2965例对照。虽然没有一种基因型与DGC风险相关,但在A等位基因携带者[比值比(OR)=1.237,95%置信区间(95%CI)为0.940 - 1.627]、CA杂合子(OR = 1.229,95%CI = 0.938 - 1.610)和AA纯合子(OR = 1.146,95%CI = 0.684 - 1.918)中发现了风险略有增加的趋势。然而,当按种族对病例进行分层时,AA纯合子在亚洲组(OR = 0.710,95%CI = 0.328 - 1.536)与其高加索对应组(OR = 1.434,95%CI = 0.657 - 3.131)之间出现了不同的趋势。综合来看,这些病例对照研究的汇总分析表明,上皮钙黏蛋白基因的-160A与DGC易感性无显著关联;然而,结果表明它在亚洲人和高加索人中都是一个潜在的遗传风险因素。需要更多大规模、设计良好的研究来证实AA纯合性是否是亚洲人的保护因素。